Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-30

Clinical Trial Update: Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating different doses of esketamine and dexmedetomidine for supplemental analgesia and long-term outcomes in scoliosis surgery; rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Esketamine (esketamine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Scoliosis Correction, Postoperative Analgesia | Phase 4 | Status: RECRUITING